Safety biomarkers in preclinical development: translational potential (Q38148980)

29 August 2017

title

Safety biomarkers in preclinical development: translational potential (English)

1 reference

29 August 2017

0 references

V G Sasseville

1

1 reference

29 August 2017

K G Mansfield

series ordinal

2

1 reference

29 August 2017

D J Brees

series ordinal

3

1 reference

29 August 2017

publication date

3 October 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

51

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

281-291

1 reference

Fourier Transform Ion Cyclotron Resonance mass spectrometry for plant metabolite profiling and metabolite identification

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Analytical characteristics of high-sensitivity cardiac troponin assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Systems pharmacology to predict drug toxicity: integration across levels of biological organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

A translational approach to detecting drug-induced cardiac injury with cardiac troponins: consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Metabolomics and its potential in drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Recommendations for the evaluation of pathology data in nonclinical safety biomarker qualification studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Quantum dot technology in flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Methodological and analytic considerations for blood biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Time course characterization of serum cardiac troponins, heart fatty acid-binding protein, and morphologic findings with isoproterenol-induced myocardial injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Internalization and transcytosis of pancreatic enzymes by the intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Luminescent quantum dots for molecular toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

NMR and MS Methods for Metabonomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

The use of immunohistochemistry for biomarker assessment--can it compete with other technologies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

The enhanced value of combining conventional and "omics" analyses in early assessment of drug-induced hepatobiliary injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

A retrospective analysis of toxicogenomics in the safety assessment of drug candidates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

The basics of mass spectrometry in the twenty-first century

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Tissue microarrays as a tool in the discovery and validation of predictive biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Biomarkers of diabetic nephropathy, the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Application of in vivo metabolomics to preclinical/toxicological studies: case study on phenytoin-induced systemic toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Reproducibility and robustness of metabolome analysis in rat plasma of 28-day repeated dose toxicity studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Preclinical applications of quantitative imaging cytometry to support drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

LC/MS applications in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Release kinetics of cardiac biomarkers in patients undergoing transcoronary ablation of septal hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Cross-study and cross-omics comparisons of three nephrotoxic compounds reveal mechanistic insights and new candidate biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Systems Biology Approaches and Applications in Obesity, Diabetes, and Cardiovascular Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Frontiers in preclinical safety biomarkers: microRNAs and messenger RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Metabolomics: an essential tool to understand the function of peroxisome proliferator-activated receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Tissue factor exposing microparticles in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Applications of laser scanning cytometry in immunohistochemistry and routine histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

The role of proteomics in prostate cancer research: biomarker discovery and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Microparticles as mediators and biomarkers of rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Androgen and androgen metabolite levels in serum and urine of East African chimpanzees (Pan troglodytes schweinfurthii): comparison of EIA and LC-MS analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Characterization of renal papillary antigen 1 (RPA-1), a biomarker of renal papillary necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Troponin as a biomarker of cardiac toxicity: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Metabonomics in toxicology: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Metabonomics in pharmaceutical discovery and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Metabonomics in preclinical drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Metabolomics in toxicology: preclinical and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Design and evaluation of immunotoxicity studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

The proteomics big challenge for biomarkers and new drug-targets discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Widely targeted metabolomics based on large-scale MS/MS data for elucidating metabolite accumulation patterns in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Increased plasma levels of microparticles expressing CD39 and CD133 in acute liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Increased toxicity when fibrates and statins are administered in combination--a metabolomics approach with rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Social correlates of variation in urinary cortisol in wild male bonobos (Pan paniscus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-α or TLR-9 agonist and GM-CSF with peptide vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Identification and elucidation of the biology of adverse events: the challenges of safety assessment and translational medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Quantification of circulating CD34 /KDR /CD45dim endothelial progenitor cells: analytical considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Metabolomics: a tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Strategic approach to fit-for-purpose biomarkers in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Circulating microRNAs, potential biomarkers for drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Opportunities and challenges of disease biomarkers: a new section in the Journal of Translational Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint Scientific Committee for International Harmonization of Clinical Pathology Testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Simultaneous measurement of endogenous steroid hormones and their metabolites with LC-MS/MS in faeces of a New World primate species, Cebus capucinus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Implementation of liquid chromatography/mass spectrometry into the clinical laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Qualified kidney biomarkers and their potential significance in drug safety evaluation and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Detection, synthesis and characterization of metabolites of steroid hormones conjugated with cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

High-resolution magic angle spinning NMR spectroscopy: Application to biomedical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

Towards consensus practices to qualify safety biomarkers for use in early drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0300985813505117

21 January 2018

Identifiers

DOI

10.1177/0300985813505117

1 reference

release_djjdoambejbojlu56j6w5rxtsa

29 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/djjdoambejbojlu56j6w5rxtsa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference